Factors associated with the development of impulse compulsive disorders in Parkinson patients

Abdul Qayyum RanaParkinson's Clinic of Eastern Toronto and Movement Disorders Center, Toronto, ON, CanadaCorrespondence[email protected]

Wasim MansoorParkinson's Clinic of Eastern Toronto and Movement Disorders Center, Toronto, ON, Canada

Syed HussainiParkinson's Clinic of Eastern Toronto and Movement Disorders Center, Toronto, ON, Canada

Abdullah Al MosabbirParkinson's Clinic of Eastern Toronto and Movement Disorders Center, Toronto, ON, Canada

Maniza RahmanParkinson's Clinic of Eastern Toronto and Movement Disorders Center, Toronto, ON, Canada

Labiba RahmanParkinson's Clinic of Eastern Toronto and Movement Disorders Center, Toronto, ON, Canada

References

Lanari A. Non-pharmacological treatment of Parkinson disease. Medicina 2000;39(4):548–9.
Google Scholar
Rana AQ, Depradine J. Abdominal pain: a symptom of levodopa end of dose wearing off in Parkinson's disease. West Indian Med J 2011;60:223–4.
PubMedGoogle Scholar
Claassen DO, Van Den Wildenberg WPM, Ridderinkhof KR, The risky business of dopamine agonists in Parkinson disease and impulse control disorders. Behav Neurosci August 2011;125(4):492—500.
PubMedGoogle Scholar
Weintraub D. Dopamine and impulse control disorders in Parkinson's disease. Ann Neurol 2008;64:S93–100.
Google Scholar
Chiang HL, Huang YS, Chen ST, Wu YR. Are there ethnic differences in impulsive/compulsive behaviors in Parkinson's disease? Eur J Neurol 2011;19:494–500.
PubMedGoogle Scholar
Joutsa J, Martikainen K, Vahlberg T, Kaasinen V. Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease. Parkinsonism Relat Disord 2012;18:1079–83.
PubMed Web of Science ®Google Scholar
Kim YE, Kim HJ, Yun JY, Jeon BS. Intravenous amantadine is safe and effective for the perioperative management of patients with Parkinson's disease. J Neurol 2011;258:2274–5.
PubMedGoogle Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Factors associated with the development of impulse compulsive disorders in Parkinson patients

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Factors associated with the development of impulse compulsive disorders in Parkinson patients

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date